Roles
- Professor of Surgery
- Secondary Appointment of Biochemistry and Molecular Biology
- Secondary appointment Microbiology and Immunology
-
Biography
Sabita Roy is a Professor and Vice Chair for Research in the Department of Surgery, at the University of Miami. She received her Ph.D. degree from the University of Kansas and pursued postdoctoral training in Pharmacology at the University of California, San Francisco. After completion of her post-doctoral training, she was recruited as an Assistant Professor and rose to the rank of professor at the University of Minnesota. In 2016 she was recruited as Professor and Vice Chair to the University of Miami.
Dr. Roy’s research is focused on delineating the role of the gut-immune brain axis in the co-morbidities associated with chronic opioid use. Her recent studies are focused on investigating the role of the gut microbiome in opioid induced tolerance, addiction, and dependence. Her research has been continuously supported by grants from the national Institute of Drug Abuse. She currently runs a T-32 training grant. She has more that 180 publications in high-ranking journals. She was the past president of Society of Neuroimmune pharmacology (SNIP) and the Section Editor of the Journal of Neuroimmune Pharmacology She has trained over 15 predoctoral students and 25 postdoctoral students. -
Education & Training
Education
Post Graduate Training
-
Honors & Awards
-
Teaching Interests
The primary focus of my training style is to mentor in an environment that promotes inclusivity and integrity. My mentees learn how to maintain records and sustain a rigorous and unbiased experimental design. My lab supports Individual development and requires all trainees to maintain an individual training plan. -
Research Interests
Opioids are the gold standard for the management of moderate to severe cancer pain. The clinical use of opioids is limited because of co-morbidities associated with extended use. The goal of Dr. Roy’s studies is to identify therapeutic targets that can prolong opioid use and minimize its co-morbidities. Their recent studies show an association between chronic opioid use and altered gut microbiome. These findings have strong implications that manipulating the gut microbiome can be a potential therapeutic target to improve the pain relieving efficacy of opioids. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Articles & News
Dr. Kristin Rojas Receives Grant to Investigate the Role Opioids May Play in Breast Cancer
Office of Graduate Studies Prepares Students for National Success
Sylvester Researchers Receive Florida Department of Health Grants
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.